`
`
`
`›
`
`
`
`
`
`Novo Nordisk Exhibit 2480
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00001
`
`/ About Us — Explore More
`OUR VISION
`Powering smarter healthcare for
`everyone, everywhere
`At IQVIA, we want to help ensure essential treatments reach
`all human beings all over the world, no matter where they are.
`To get there, we work with customers and partners to
`accelerate their results and address unmet needs.
`About
`JUMP TO
`
`
`Novo Nordisk Exhibit 2480
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00002
`
`OUR PEOPLE
`We are focused on driving
`healthcare forward, supported by
`four key principles
`Passion
`We strive to make a positive impact in
`everything we do.
`Innovation
`We approach every problem with
`curiosity and an open-mind to better
`support our customers’ innovations.
`Collaboration
`We aim to bring out
`other and our divers
`maximize our positiv
`working together.
`
`
`Novo Nordisk Exhibit 2480
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00003
`
`IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical
`research services to the life sciences industry. IQVIA creates intelligent connections across all
`aspects of healthcare through its analytics, transformative technology, big data resources and
`extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with
`speed and agility — enabling customers to accelerate the clinical development and
`commercialization of innovative medical treatments that improve healthcare outcomes for
`patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100
`countries.
`Explore More
`IQVIA Patient Experience Solutions powered by Apple
`
`
`Novo Nordisk Exhibit 2480
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00004
`
`Our Impact
`IQVIA Connected Intelligence
`Environmental, Social and Governance
`Commitment to Public Health
` Code of Conduct
`Innovation Hub
`Leadership
`Privacy
`Third Party Access Program
`You may also be interested in
`Featured Innovations
`The IQVIA Institute
`Insights Library
`
`
`Novo Nordisk Exhibit 2480
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00005
`
`Investor Relations
`Customer Portal
`Careers
`Code of Conduct
`Events
`Contact Us
`Third-Party Access
`Suppliers
`Privacy
`Your Privacy Choices
`Terms of Use
`Sitemap
`©2023 IQVIA Inc, All Rights Reserved.
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
